Jiangsu Yangnong Chemical Co., Ltd. (SHA:600486)
China · Delayed Price · Currency is CNY 71.46
+0.42 (0.59%)
At close: Feb 6, 2026
Jiangsu Yangnong Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 11,410 | 10,270 | 11,285 | 15,555 | 11,710 | 9,754 |
Other Revenue | 165.14 | 165.14 | 192.43 | 255.55 | 131.27 | 76.78 |
| 11,575 | 10,435 | 11,478 | 15,811 | 11,841 | 9,831 | |
Revenue Growth (YoY) | 13.26% | -9.09% | -27.41% | 33.52% | 20.45% | 12.98% |
Cost of Revenue | 9,056 | 8,037 | 8,564 | 11,769 | 9,117 | 7,259 |
Gross Profit | 2,519 | 2,398 | 2,914 | 4,042 | 2,725 | 2,572 |
Selling, General & Admin | 641.91 | 695.31 | 744.68 | 1,180 | 850.24 | 715.9 |
Research & Development | 386.4 | 358.16 | 418.03 | 498.02 | 373.53 | 332.33 |
Other Operating Expenses | 18.09 | -5.83 | 47.41 | 43.84 | 28.59 | 28.77 |
Operating Expenses | 1,097 | 1,035 | 1,121 | 1,821 | 1,288 | 1,077 |
Operating Income | 1,422 | 1,363 | 1,793 | 2,220 | 1,437 | 1,495 |
Interest Expense | -41.33 | -64.61 | -45.83 | -59.44 | -42.56 | -53.79 |
Interest & Investment Income | 126.02 | 124.48 | 95.29 | 29.53 | 48.92 | 40.62 |
Currency Exchange Gain (Loss) | 11.13 | 11.13 | 12.76 | 279.94 | -59.29 | -134.73 |
Other Non Operating Income (Expenses) | -9.93 | -7.48 | -3.46 | -4.08 | -6.28 | -7.74 |
EBT Excluding Unusual Items | 1,508 | 1,427 | 1,851 | 2,466 | 1,377 | 1,339 |
Gain (Loss) on Sale of Investments | -4.52 | -3.19 | -11.67 | -186.94 | 42.82 | 116.29 |
Gain (Loss) on Sale of Assets | 0.04 | 15.85 | 5.06 | 1.9 | 0.53 | -0.55 |
Asset Writedown | -59.24 | -60.16 | -6.57 | -171.73 | -0.95 | -52.88 |
Other Unusual Items | 26.68 | 26.68 | 27.87 | 25.77 | 20.68 | 17.38 |
Pretax Income | 1,471 | 1,406 | 1,866 | 2,135 | 1,440 | 1,420 |
Income Tax Expense | 238.62 | 203.17 | 299.98 | 339.69 | 217.4 | 208.77 |
Earnings From Continuing Operations | 1,232 | 1,203 | 1,566 | 1,796 | 1,223 | 1,211 |
Minority Interest in Earnings | -0.77 | -0.88 | -1.15 | -1.44 | -0.99 | -1.11 |
Net Income | 1,232 | 1,202 | 1,565 | 1,794 | 1,222 | 1,210 |
Net Income to Common | 1,232 | 1,202 | 1,565 | 1,794 | 1,222 | 1,210 |
Net Income Growth | 0.13% | -23.19% | -12.77% | 46.82% | 1.02% | 3.41% |
Shares Outstanding (Basic) | 402 | 404 | 405 | 403 | 403 | 403 |
Shares Outstanding (Diluted) | 402 | 404 | 405 | 403 | 403 | 403 |
Shares Change (YoY) | -1.20% | -0.24% | 0.42% | 0.00% | 0.02% | -0.01% |
EPS (Basic) | 3.07 | 2.98 | 3.87 | 4.45 | 3.03 | 3.00 |
EPS (Diluted) | 3.07 | 2.98 | 3.87 | 4.45 | 3.03 | 3.00 |
EPS Growth | 1.34% | -23.01% | -13.14% | 46.81% | 1.00% | 3.42% |
Free Cash Flow | -138.42 | 320.12 | 876.64 | 956.94 | 122.35 | 215.22 |
Free Cash Flow Per Share | -0.34 | 0.79 | 2.17 | 2.38 | 0.30 | 0.53 |
Dividend Per Share | 0.920 | 0.680 | 0.880 | 1.000 | 0.500 | 0.500 |
Dividend Growth | 4.54% | -22.73% | -12.00% | 100.00% | - | - |
Gross Margin | 21.76% | 22.98% | 25.39% | 25.56% | 23.01% | 26.17% |
Operating Margin | 12.29% | 13.07% | 15.62% | 14.04% | 12.13% | 15.21% |
Profit Margin | 10.64% | 11.52% | 13.63% | 11.35% | 10.32% | 12.31% |
Free Cash Flow Margin | -1.20% | 3.07% | 7.64% | 6.05% | 1.03% | 2.19% |
EBITDA | 2,092 | 2,063 | 2,533 | 2,862 | 2,013 | 1,885 |
EBITDA Margin | 18.07% | 19.77% | 22.07% | 18.10% | 17.00% | 19.18% |
D&A For EBITDA | 669.45 | 699.81 | 740.29 | 641.76 | 576.62 | 390.41 |
EBIT | 1,422 | 1,363 | 1,793 | 2,220 | 1,437 | 1,495 |
EBIT Margin | 12.29% | 13.07% | 15.62% | 14.04% | 12.13% | 15.21% |
Effective Tax Rate | 16.22% | 14.45% | 16.07% | 15.91% | 15.09% | 14.71% |
Revenue as Reported | 11,575 | 10,435 | 11,478 | 15,811 | 11,841 | 9,831 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.